Condition
Dacryostenosis
Total Trials
2
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Balanced Salt Solution
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
100%
2 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
2Total
Phase 4 (2)
Trial Status
Terminated1
Recruiting1
Clinical Trials (2)
Research Network
Common Treatments
- Balanced Salt Solution2
- Proparacaine Hydrochloride Ophthalmic Solution Usp 052
Active Sponsors
- Corewell Health East1
- Louisiana State University Health Sciences Center in New Orleans1
Top Investigators
LSU Health Sciences Center
Corewell Health East
Related Conditions
- Dacryocystitis2
- Epiphora2